In the vaccine model, eight out of ten mice (80%) of the IgG/vac group were cured of the high dose 7 day established tumors, compared with tumor only control (p=0.009), whereas administration of CD24-Fc at the start of vaccination resulted in 55% cure, which was better than controls (13% cure) without vaccine, but was not statistically significant (p=0.1) (Figure 6A). Here, CD24 is linked to neoplasm.